<DOC>
	<DOCNO>NCT02797028</DOCNO>
	<brief_summary>The purpose study confirm protective effect mechanism anthocyanins hyperuricemia patient Cardiovascular disease .</brief_summary>
	<brief_title>Investigation Atherogenic Effects Uric Acid-modified Endothelial Dysfunction Preventional Mechanism Anthocyanidines</brief_title>
	<detailed_description>Hyperuricemia patient ability complete intervention study early stage study select research subject . A randomized control double blind control method use study effect one year anthocyanins intervention . Serum UA level , oxidative stress , AGEs , endothelial function detect patient hyperuricemia treat anthocyanins placebo . Providing scientific basis anthocyanins treatment hyperuricemia delay atherosclerosis .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Allopurinol</mesh_term>
	<mesh_term>Proanthocyanidin</mesh_term>
	<criteria>Serum uric acid &gt; 420μmol/L ( 7mg/dL ) male , &gt; 360μmol/L ( 6mg/dL ) female identify hyperuricemia patient . Age 60 year less 30 year old ; acute infection , tumor , recent surgery , need hemodialysis autoimmune disease .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Hyperuricemia</keyword>
	<keyword>endothelial function</keyword>
	<keyword>anthocyanidins</keyword>
</DOC>